- Study of the Genes Responsible for the Drug Resistance of Mucobacterium tuberculosis and Their Application for Rapid Diagnosis
-
Suzuki Y
- KMID: 2099333
- J Korean Soc Microbiol.
- 2000 Oct;35(5):333-335.
No Abstract Available. -
- CITED
-
- Close
- SHARE
-
- Close
- Splenic infarction associated with acute infectious mononucleosis
-
Suzuki Y, Kakisaka K, Kuroda H, Sasaki T, Takikawa Y
- KMID: 2411561
- Korean J Intern Med.
- 2018 Mar;33(2):451-452.
- doi: 10.3904/kjim.2016.394
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Bidirectional Longitudinal Association between Back Pain and Loneliness in Later Life: Evidence from English Longitudinal Study of Ageing
-
Suzuki Y, Suzuki T, Takagi M, Murakami M, Ikeda T
- KMID: 2553847
- Ann Geriatr Med Res.
- 2024 Mar;28(1):27-35.
- doi: 10.4235/agmr.23.0136
Background: This study examined the bidirectional and temporal-ordinal relationship between loneliness and back pain. Methods: Data from 7,730 participants in waves 6 (2012–2013), 7 (2014–2015), and 8 (2016–2017) of the national... -
- CITED
-
- Close
- SHARE
-
- Close
- Transcatheter Arterial Chemotherapy with Miriplatin for Hepatocellular Carcinoma Patients with Chronic Renal Failure: Report of Three Cases
-
Imai N, Ikeda K, Seko Y, Kawamura Y, Sezaki H, Hosaka T, Akuta N, Kobayashi , Saitoh S, Suzuki F, Suzuki Y, Arase Y, Kumada H
- KMID: 2135078
- Gut Liver.
- 2013 Mar;7(2):246-251.
Miriplatin is a novel lipophilic platinum complex that was developed to treat hepatocellular carcinoma (HCC). Although HCC patients frequently have coexisting chronic renal failure, little prospective data are available regarding... -
- CITED
-
- Close
- SHARE
-
- Close
- Rapid Identification of bla(IMP-1) and bla(IMP-6) by Multiplex Amplification Refractory Mutation System PCR
-
Nakano A, Nakano R, Suzuki Y, Saito K, Kasahara K, Endo S, Yano H
- KMID: 2408080
- Ann Lab Med.
- 2018 Jul;38(4):378-380.
- doi: 10.3343/alm.2018.38.4.378
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- What Is the Most Effective Drug Delivery System for Cisplatin during the Treatment of Hepatic Tumors with Single-Session Transcatheter Chemotherapy? A Pilot Study
-
Kawamura Y, Ikeda K, Fukushima , Seko Y, Hara T, Sezaki H, Hosaka T, Akuta N, Kobayashi , Saitoh S, Suzuki F, Suzuki Y, Arase Y, Kumada H
- KMID: 1806675
- Gut Liver.
- 2013 Sep;7(5):576-584.
BACKGROUND/AIMS: The aim of this study was to determine the pharmacodynamics of cisplatin following three different treatment procedures for intrahepatic arterial infusion therapy for hepatocellular carcinoma (HCC). METHODS: We divided 13... -
- CITED
-
- Close
- SHARE
-
- Close
- Beneficial effects of tonsillectomy plus steroid pulse therapy on inflammatory and tubular markers in patients with IgA nephropathy
-
Maruyama S, Gohda T, Suzuki Y, Suzuki H, Sonoda Y, Ichikawa S, Li Z, Murakoshi , Horikoshi , Tomino Y
- KMID: 2364288
- Kidney Res Clin Pract.
- 2016 Dec;35(4):233-236.
- doi: 10.1016/j.krcp.2016.09.002
BACKGROUND: IgA nephropathy (IgAN) is the most common form of primary glomerulonephritis worldwide. Tonsillectomy plus steroid pulse therapy has been able to induce clinical remission in early-stage IgAN. However, its... -
- CITED
-
- Close
- SHARE
-
- Close
- Soluble extract of soybean fermented with Aspergillus oryzae GB107 inhibits fat accumulation in cultured 3T3-L1 adipocytes
-
So KH, Suzuki Y, Yonekura S, Suzuki Y, Lee CH, Kim SW, Katoh K, Roh SG
- KMID: 2313863
- Nutr Res Pract.
- 2015 Aug;9(4):439-444.
- doi: 10.4162/nrp.2015.9.4.439
BACKGROUND/OBJECTIVES: This study was conducted to investigate the effects of fermented soybean (FS) extract on adipocyte differentiation and fat accumulation using cultured 3T3-L1 adipocytes. MATERIALS/METHODS: 3T3-L1 adipocytes were treated with FS... -
- CITED
-
- Close
- SHARE
-
- Close
- Relationships between Genetic Variations of PNPLA3, TM6SF2 and Histological Features of Nonalcoholic Fatty Liver Disease in Japan
-
Akuta N, Kawamura Y, Arase Y, Suzuki F, Sezaki H, Hosaka T, Kobayashi , Kobayashi , Saitoh S, Suzuki Y, Ikeda K, Kumada H
- KMID: 2411972
- Gut Liver.
- 2016 May;10(3):437-445.
- doi: 10.5009/gnl15163
BACKGROUND/AIMS: It is important to determine the noninvasive parameters of histological features in nonalcoholic fatty liver disease (NAFLD). The aim of this study was to investigate the value of genetic... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of postoperative nausea and vomiting between remimazolam and propofol: a propensity score-matched, retrospective, observational, single-center cohort study
-
Suzuki Y, Kawashima S, Makino H, Doi M, Nakajima Y
- KMID: 2541004
- Korean J Anesthesiol.
- 2023 Apr;76(2):143-151.
- doi: 10.4097/kja.22441
Background: Remimazolam is a novel ultrashort-acting benzodiazepine that has recently become available for general anesthesia. However, the incidence of postoperative nausea and vomiting (PONV) associated with remimazolam remains unknown. In... -
- CITED
-
- Close
- SHARE
-
- Close
- The efficacy of a novel integrated outside biliary stent and nasobiliary drainage catheter system for acute cholangitis: a single center pilot study
-
Kuraoka N, Ujihara T, Kasahara H, Suzuki Y, Sakai S, Hashimoto S
- KMID: 2547902
- Clin Endosc.
- 2023 Nov;56(6):795-801.
- doi: 10.5946/ce.2022.289
Background/Aims: Endoscopic biliary drainage is the gold standard treatment for cholangitis. The two methods of biliary drainage are endoscopic biliary stenting and nasobiliary drainage. A novel integrated outside biliary stent... -
- CITED
-
- Close
- SHARE
-
- Close
- Hyperfractionated radiotherapy for re-irradiation of recurrent esophageal cancer
-
Takeda K, Matsushita H, Umezawa R, Yamamoto T, Ishikawa Y, Takahashi N, Suzuki Y, Jingu K
- KMID: 2523728
- Radiat Oncol J.
- 2021 Dec;39(4):265-269.
- doi: 10.3857/roj.2021.00325
Purpose: Re-irradiation is a treatment option for recurrent esophageal cancer patients with a history of radiotherapy, but there is a risk of severe late adverse effects. This study focused on... -
- CITED
-
- Close
- SHARE
-
- Close
- Early wound healing of the hard-palate mucosal harvest site using artificial dermis fixation by a transparent plate
-
Suzuki Y, Tanaka I, Sakai S, Yamauchi T
- KMID: 2514037
- Arch Plast Surg.
- 2021 Mar;48(2):208-212.
- doi: 10.5999/aps.2020.00843
Background There are currently no guidelines for the postoperative wound management of the hard-palate donor site in cases involving mucosal harvesting. This study describes our experiences with the use of... -
- CITED
-
- Close
- SHARE
-
- Close
- Indocyanine green fluorescence videoangiography for reliable variations of supraclavicular artery flaps
-
Suzuki Y, Shimizu Y, Kasai S, Yamazaki S, Takemaru M, Kitamura T, Kawakami S, Tamura T
- KMID: 2459657
- Arch Plast Surg.
- 2019 Jul;46(4):318-323.
- doi: 10.5999/aps.2018.01536
BACKGROUND: Pedicled flaps are useful for reconstructive surgery. Previously, we often used vascularized supraclavicular flaps, especially for head and neck reconstruction, but then shifted to using thoracic branch of the... -
- CITED
-
- Close
- SHARE
-
- Close
- Proximal ligation after the side-to-end anastomosis recovery technique for lymphaticovenous anastomosis
-
Suzuki Y, Sakuma H, Ihara J, Shimizu Y
- KMID: 2459661
- Arch Plast Surg.
- 2019 Jul;46(4):344-349.
- doi: 10.5999/aps.2018.01382
BACKGROUND: Lymphaticovenous anastomosis is an important surgical treatment for lymphedema, with lymphaticovenous side-to-end anastomosis (LVSEA) and lymphaticovenous end-to-end anastomosis being the most frequently performed procedures. However, LVSEA can cause lymphatic... -
- CITED
-
- Close
- SHARE
-
- Close
- Reduction of Bladder Capacity Under Anesthesia Following Multiple Recurrences and Repeated Surgeries of Hunner Lesions in Patients With Interstitial Cystitis
-
Furuta A, Suzuki Y, Igarashi T, Kimura T, Egawa S, Yoshimura N
- KMID: 2528266
- Int Neurourol J.
- 2022 Mar;26(1):45-51.
- doi: 10.5213/inj.2142102.051
Purpose: To investigate the influence of multiple recurrences and repeated surgeries of Hunner lesions on bladder capacity under general anesthesia in patients with interstitial cystitis (IC). Methods: We retrospectively reviewed the... -
- CITED
-
- Close
- SHARE
-
- Close
- Postoperative norepinephrine versus dopamine in patients undergoing noncardiac surgery: a propensity-matched analysis using a nationwide intensive care database
-
Aoki Y, Nakajima M, Sugimura S, Suzuki Y, Makino H, Obata Y, Doi M, Nakajima Y
- KMID: 2548312
- Korean J Anesthesiol.
- 2023 Oct;76(5):481-489.
- doi: 10.4097/kja.22805
Background: Choosing catecholamines, such as norepinephrine and dopamine, for perioperative blood pressure control is essential for anesthesiologists and intensivists. However, studies specific to noncardiac surgery are limited. Therefore, we aimed... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and safety of two pH-dependent-release mesalamine doses in moderately active ulcerative colitis: a multicenter, randomized, double-blind, parallel-group study
-
Suzuki Y, Iida M, Ito H, Saida I, Hibi T
- KMID: 2174510
- Intest Res.
- 2016 Jan;14(1):50-59.
- doi: 10.5217/ir.2016.14.1.50
BACKGROUND/AIMS: The therapeutic effect of mesalamine is considered to be dose-dependent; however, no consensus has been reached regarding the optimal doses for individual patients. This study aimed to provide new... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of elemental diet combined with infliximab dose escalation in patients with Crohn's disease with loss of response to infliximab: CERISIER trial
-
Hisamatsu , Kunisaki R, Nakamura S, Tsujikawa , Hirai F, Nakase H, Watanabe K, Yokoyama K, Nagahori M, Kanai T, Naganuma M, Michimae H, Andoh A, Yamada A, Yokoyama T, Kamata N, Tanaka S, Suzuki Y, Hibi T, Watanabe M, CERISIER Trial group
- KMID: 2417663
- Intest Res.
- 2018 Jul;16(3):494-498.
- doi: 10.5217/ir.2018.16.3.494
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance
-
Nakamura S, Asano T, Tsuchiya H, Sugimoto K, Imai Y, Yokoyama S, Suzuki Y
- KMID: 2531987
- Intest Res.
- 2022 Jul;20(3):329-341.
- doi: 10.5217/ir.2021.00032
Background/Aims: Golimumab (GLM) is an anti-tumor necrosis factor-α drug approved for treating moderate-to-severe active ulcerative colitis (UC). A 52-week post-marketing surveillance (PMS) was initiated to evaluate its safety and effectiveness... -
- CITED
-
- Close
- SHARE
-
- Close
